U.S. DISINFECTING CAP MARKET ANALYSIS

The U.S. disinfecting cap market is estimated to be valued at US$ 534.1 Million in 2023, exhibiting a CAGR of 10.9% during the forecast period (2023-2030).

Analysts’ Views on the U.S. Disinfecting Cap Market

The U.S. disinfecting cap market growth is expected to witness growth, owing to increasing tnumber of hospital-acquired infections in the U.S. For instance, in February 2022, according to the data published by the U.S. Center for Disease Control and Prevention, 1.7 million hospitalized patients annually acquire hospital-acquired infections while being treated for other health issues, and more than 98,000 patients (one in 17) die annually from hospital-acquired infections in U.S.

Figure 1. U.S. Disinfecting Cap Market Share (%), By Application, 2023

To learn more about this report, request sample copy

U.S. Disinfecting Cap Market– Drivers

Increasing Prevalence of Blood Stream Infections Associated with Central venous access devices (CVADs)

 Increasing prevalence of blood stream infections associated with C-VADs is expected to drive the U.S. disinfecting cap market growth over the forecast period. According to the data published by government of Canada, in 2021, Canadian women aged 65 and older are more likely to be diagnosed with gynecological disorders. Furthermore, it was stated that 90%of all blood stream infections are associated with C-VADs and 400,000 Central Line-associated Blood Stream Infections (CLABSIs) are reported every year in the U.S.

Figure 2. U.S. Disinfecting Cap Market Share (%), By End User, 2023

To learn more about this report, request sample copy

U.S. Disinfecting Cap Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries worldwide, and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, the U.A.E., Egypt, and others, faced problems regarding  transportation of drugs from one place to another.

During the COVID-19 pandemic, the U.S. disinfecting cap market growth was hampered due to the increased risk of infection among patients. For instance, in May 2021, according to the data published by National Center For Biotechnology Information, due to COVID-19, the number of surgical procedures among patients had decreased, and thus, demand for surgical instruments such as disinfecting caps were decreased.

U.S. Disinfecting Cap Market- Segmentation

The U.S. disinfecting cap market is segmented into application, type, and end user.

Based on Application, the market is segmented into central venous line, peripheral IV catheters, and others (blood collection). Out of which, the central venous line segment is expected to hold a dominant position in the U.S. disinfecting cap market over the forecast period owing to  rising incidence of central line-associated blood stream infections.

Based on Type, the market is segmented into single cap system and double cap system. Out of which,, the double cap system segment is expected to hold a dominant position in the U.S. disinfecting cap market over the forecast period owing to increasing demand for double cap system as  it can be used for rapid disinfection.

Based on End User, the market is segmented into hospital and clinics, ambulatory surgical centers, and others (outpatient surgical centers, etc.). Out of which,, the hospital and clinics segment is expected to dominate the market over the forecast period, as hospital  and clinics are major end users of disinfecting caps as these caps are majorly used to protect catheters and I.V. access points from contamination risks.

Among all segmentations, the application segment has the highest growth potential due to the high adoption of disinfecting caps for the prevention of central line-associated blood stream infections.

U.S. Disinfecting Cap Market - Key Developments

Increasing research studies for the effective use of disinfecting caps to reduce passive infection is expected to drive the U.S. disinfecting cap market growth over the forecast period. For instance, in August 2020, according to the data published by National Center for Biotechnology Information, a study was conducted among oncology patients in tertiary care cancer center in New York, the U.S., which concluded that the routine use of disinfecting caps is associated with decreased hospital-acquired central line associated bloodstream infections and blood culture contamination among hematology-oncology patients.

U.S. Disinfecting Cap Market: Restraint

Availability Of Substitutes For Disinfecting Cap

 Increasing availability of substitutes for disinfecting capincluding antimicrobial-coated central venous catheters such as Certofix protect, Cook Spectrum Central Venous Catheter, and ARROW CVC with ARROWg+ard Technology is expected to hamper the market growth.

U.S. Disinfecting Cap Market - Key Players

The major players operating in the U.S. disinfecting cap market are ICU Medical, BD, 3M, Merit Medical Systems, Omnia Health, B. Braun SE, Agilent Technologies Inc., Biocrates Lifescience AG, Bio-Rad Laboratories Inc., and Pursuit Vascular Inc.

*Definition: Disinfecting caps are widely used for the prevention of Central Line-associated Bloodstream Infection (CLABSI). Peripheral IV catheter insertion is one of the most common invasive procedures in hospital settings. PIVC are intravenous devices that are used more frequently that increases risk of infection. As a result, special infection control measures are applied for such IV devices (catheter hub, syringe hub and needle). In order to avoid contamination risks, most hospitals use PIV bundles including disinfecting caps and tips. Central venous line procedures are generally used for hemodynamic monitoring.